Detalhe da pesquisa
1.
Interstitial lung disease with myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis in elderly patients.
Rheumatol Int
; 41(9): 1641-1650, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34056682
2.
Clinical features of dermatomyositis associated with anti-MDA5 antibodies by age.
Mod Rheumatol
; 31(1): 177-185, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-32149542
3.
Glasgow prognostic score and body mass index predict short-term discontinuation of the antifibrotic agents pirfenidone and nintedanib.
Respir Investig
; 62(3): 388-394, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38460356
4.
Differential Discontinuation Profiles between Pirfenidone and Nintedanib in Patients with Idiopathic Pulmonary Fibrosis.
Cells
; 11(1)2022 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35011705
5.
Immune-related adverse events caused by treatment with pembrolizumab in a patient with lung cancer who infected influenza virus.
Respir Med Case Rep
; 32: 101361, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33643837
6.
Clinical features of patients with anti-melanoma differentiation-associated gene-5 antibody-positive dermatomyositis complicated by spontaneous pneumomediastinum.
Clin Rheumatol
; 38(12): 3443-3450, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31420814
7.
Letter to the Editor: Three Cases of Pain Treatment in Cancer Patients Using an Alternating Magnetic Field Therapy Device.
J Palliat Med
; 26(11): 1444-1445, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37955879
8.
Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
Respir Med
; 140: 1-5, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29957268